ProHealth health Resource
 SUBSCRIBE TO OUR FREE E-NEWSLETTERS  
Click Here to Preview
Log In
Catalog Quick Order
Your Account
Shopping Cart
 Check Out
ProHealth: News, Research, Vitamins & Supplements About ProHealth ProHealth ImmuneSupport.com ProHealth Online Vitamin & Supplement Store ProHealth Treatment & Research Library ProHealth Community ProHealth Vitamins & Supplements Catalog
Your Purchase Helps Fund Health Research
Explore Our Health Sites
ProHealth Vitamin and Supplement Catalog
Your resource for specialty nutritional supplements, books, DVDs, resources for better living, health news & more!
ProHealth Health & Wellness Research & News Catalog
Your Purchases Help Fund Ongoing Research
 
 
Search our extensive library for information, solutions & support
Site
Message Board  
Abstracts
Newsletters  
Articles
Products  

Rice University Receives Grant to Develop New Cartilage for Damaged Joints

April 30, 2003

Rice University has received a $1.7 million grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to develop biodegradable plastics that can be injected in place of damaged or missing cartilage, acting as template for the re-growth of healthy cartilage.

The research addresses a persistent and widespread problem: there is no synthetic alternative to human cartilage, which is often unable to heal itself following injury. As a result, millions of Americans suffering from arthritis and joint injuries have limited treatment options.

"Over the years, doctors have tried many methods to replace injured cartilage," said Tony Mikos, the John W. Cox Professor of Bioengineering and principal investigator of the project. "They can use grafts -- either from the patient’s own body or from donors. Another option is to perform surgery to encourage the body to regrow its own cartilage or to inject cartilage cells straight into the injury. However, all of the current therapies have associated limitations."

At this time, most treatment options for damaged cartilage involve surgery, and in many cases, the replacement cartilage is weaker and more susceptible to re-injury than native tissue.

A common current treatment is allografting -- transplants involving donor tissue from another person. Mikos’ tissue engineering team hopes to develop new, noninvasive treatment options that eliminate the need for large surgeries and avoid problems associated with allografts such as tissue rejection and disease transmission.

They envision doing this by harvesting a few of the patient’s own bone marrow cells and using those to grow more. These marrow cells will be included in the biodegradable polymer that is injected into the wound. The polymer is a polyester of fumaric acid -- a natural metabolite -- and can be administered as a liquid that turns into a semi-rigid gel after several minutes in the body. This semi-rigid filler, known as a scaffold, acts as a template for newly grown cartilage. The scaffold is designed to break down over time as new cartilage fills the wound.

There are several different kinds of cartilage in the body. Mikos’ research will focus on articular cartilage, the kind that covers the ends of bones in joints. The scaffold, which will be injected into the defect in the articular cartilage, will be seeded with adult precursor cells from the bone marrow. These undeveloped cells may become chondrocytes -- the type of cells found in cartilage -- in the presence of biochemical triggers found inside the joint. Ideally, these cells could even develop into different variants of chondrocytes, depending upon where they are located in the wound. For example, those closest to the bone would form a calcified type of cartilage that bonds directly to bone, while those at the surface would form a thin sheen of tissue with the incredible strength needed to withstand the shear forces where the bones meet.

The five-year grant will fund studies to find the optimum formulation for the polymer scaffold. Mikos’ group must strike a balance, finding a material that is strong enough to do the job, while retaining the ability to be dissolved by chondrocyte enzymes that form when new cartilage grows. Ultimately, the group hopes to produce a two-layered scaffold that will promote cartilage formation in the top half and bone formation in the lower half.

DISCUSS THIS ARTICLE   (0 existing comments) Post a Comment 
health Research Articles



[ Be the first to comment on this article ]




Rice University Receives Grant to Develop New Cartilage for Damaged Joints Article Tools
Print Page Print Page Email Article Email Article
Discuss Discuss
  Rate This
Most Viewed Articles & Abstracts
Chocolate's Potential Health Benefits – and its Effect on Chronic Fatigue Syndrome Patients [more]

USDA Food Guide Pyramid [more]

Friday, Dec 5: Live Chat with ME/CFS Research Expert Suzanne Vernon, PhD – “Working to Translate Sci... [more]

Vitamin D Experts' “Call to Action” Urges Major RDA Increase to 2000 IU [more]

Vitamin D and mood disorders among women: An integrative review - Source: Journal of Midwifery and W... [more]

Featured Vitamins, Supplements, and Health Products
Vitamin Organizer (7-compartment)  -  Clear Vitamin Organizer (7-compartment) - Clear
Holds 50 pills
Quercetin / Bromelain Complex Quercetin / Bromelain Complex
Promote healthy inflammation response
ImmPower ImmPower
Enhanced NK cell production and optimal T-cell & macrophage activity
Vitamin E with Mixed Tocopherols 400 IU Vitamin E with Mixed Tocopherols 400 IU
All natural vitamin E
CorvalenM<sup>®</sup> CorvalenM®
Optimal mix of D-ribose, magnesium & malate
Security Enabled AlertSite is a leading provider of Web site monitoring and performance management solutions that help businesses ensure optimum Web experiences for their customers. TrustE Better Business Bureau BizRate Customer Certified (GOLD) Site
ProHealth Vitamin and Supplement SmartSavings Club

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
ADVANCED MEDICAL LABS   |   WHOLESALE   |   AFFILIATES   |   CONTACT US   |   PRIVACY   |   GLOSSARY   |   CUSTOMER SERVICE   |   RELATED SITES   |   RSS
Email us or Call toll-free 800-366-6056 · Monday through Friday, 7 a.m.-5 p.m. Pacific Time
International Callers dial 001.805.564.3064
Copyright © 2009 ProHealth, Inc.